Evidence map›Paper›PMID 28649602›Full record

ArticleNPJ Parkinson's disease2017

Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's disease.

Rashmi Lakshminarayana, Duolao Wang, David Burn, K Ray Chaudhuri, Clare Galtrey, Natalie Valle Guzman, Bruce Hellman, Ben James, Suvankar Pal, Jon Stamford and 9 more

Erratum issuedAbstract read
In one paragraph

Article in NPJ Parkinson's disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 48 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Supporting Medication Adherence in Parkinson's Through Education: A Scoping Review of Interventions.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Rashmi LakshminarayanauMotif Ltd, London, UK.
Duolao WangLiverpool School of Tropical Medicine, Liverpool, UK.
David BurnNewcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
K Ray ChaudhuriKing's College Hospital NHS Foundation Trust, London, UK.
Clare GaltreySt George's Healthcare Trust, London, UK.
Natalie Valle GuzmanJohn van Geest Centre for Brain Repair, Cambridge, UK.
Bruce HellmanuMotif Ltd, London, UK.
Ben JamesuMotif Ltd, London, UK.
Suvankar PalNHS Forth Valley, Scotland, UK.
Jon StamfordCure Parkinson's Trust, London, UK.
Malcolm SteigerThe Walton Centre NHS Foundation Trust, Liverpool, UK.
R W StottJohn van Geest Centre for Brain Repair, Cambridge, UK.
James TeoKing's College Hospital NHS Foundation Trust, London, UK.
Roger A BarkerJohn van Geest Centre for Brain Repair & Cambridge University Hospitals NHS Trust, Cambridge, UK.
Emma WangQueen Mary University of London, London, UK.
Bastiaan R BloemRadboud University Medical Center, Nijmegen, The Netherlands.
Martijn van der EijkRadboud University Medical Center, Nijmegen, The Netherlands.
Lynn RochesterNewcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
Adrian WilliamsUniversity Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The progressive nature of Parkinson's disease, its complex treatment regimens and the high rates of comorbid conditions make self-management and treatment adherence a challenge. Clinicians have limited face-to-face consultation time with Parkinson's disease patients, making it difficult to comprehensively address non-adherence. Here we share the results from a multi-centre (seven centres) randomised controlled trial conducted in England and Scotland to assess the impact of using a smartphone-based Parkinson's tracker app to promote patient self-management, enhance treatment adherence and quality of clinical consultation. Eligible Parkinson's disease patients were randomised using a 1:1 ratio according to a computer-generated random sequence, stratified by centre and using blocks of variable size, to intervention Parkinson's Tracker App or control (Treatment as Usual). Primary outcome was the self-reported score of adherence to treatment (Morisky medication adherence scale -8) at 16 weeks. Secondary outcomes were Quality of Life (Parkinson's disease questionnaire -39), quality of consultation for Parkinson's disease patients (

Identifiers

PMID28649602
PMCPMC5460235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.